Since the China's new healthcare reform has launched , beneficial policies introduced by the central and local governments has promoted the rapid development of private hospitals .This paper taking Sichuan Province as an ex-ample analyzes the development of private hospitals from four points of view:hospital amount, scale, location and services package, using 2002—2014 hospital-level data, which provides decision support for formulating and improving relative pol-icies.As per the analysis of the data at hand , it has been confirmed that private sector has developed quickly during the 13 years, with the number of hospitals increasing by 19.2%annually.Private hospitals were mainly of small-scale.Although the proportion of services provided by privates sector has grown yearly , it was merely 14.5%in 2014.The hospital location that the private sector selected concentrated mainly in developed regions , but the proportion of private hospital in the un-derdeveloped region has risen steadily .In terms of types of service provided , there were certain differences between private and public sector.Compared to the public sector, the private sector provided a higher proportion of specialized medical services, concentrating on otolaryngology , cosmetic plastic surgery , cardiovascular services , etc.

objective This paper analyzes the physical examination results of blood routine, chromosome deformity rate, micronucleus rate and thyroid function test of some radiation workers in Chongqing from 2018 to 2019, understands the occupational problems of radiation workers, and provide scientific basis for putting forward reasonable suggestions method:Methods 2656 cases in 2018 and 2922 cases in 2019 were selected through the information platform of physical examination system. A total of 5578 physical examination results in two years were statistically analyzed and analyzed. Results The abnormal rate of blood routine, the detection rate and abnormal rate of chromosome distortion and micronucleus, and the abnormal rate of thyroid gland function (T3, T4, TSH) between the control group and the radiation group are significant differences (P < 0.05). There were significant differences in the abnormal rate of blood routine, thyroid function (T3, T4, TSH), chromosome teratosis rate, micronucleus detection rate and abnormal rate between radiation diagnosis and treatment and industrial flaw detection, but there was no significant difference in the abnormal rate of chromosome (P > 0.05). There was significant difference between < 10 year group and 10 ～20 year group, and there was significant difference in platelet, white blood cell and hemoglobin between 10 ～20 year group and 20 year group (P < 0.05). There was no statistical significance in erythrocyte difference (P > 0.05). There was significant difference in the abnormal rate of thyroid function among the three working age segments (P < 0.05). The detection rate of chromosome distortion was significantly different between < 10 years group and 10 ～20 year group (P < 0.05), but there was no significant difference between the other two groups (P > 0.05). There was significant difference in the abnormal rate between the two groups (P < 0.05). There was no significant difference in pairwise comparison of micronucleus detection rate among groups (P > 0.05), but there was significant difference in abnormal rate among groups (P < 0.05). Conclusion The long-term low dose ionizing radiation environment will damage the hematopoietic and endocrine system of radiation sensitive human body.

Objective: To study the active ingredients in the root bark of Aralia echinocaulis. Methods: Three triterpenoid saponins were separated from the 70% ethanol extracts and purified by column chromatography and their structures were determined by spectroscopic analysis. Compound 1 and 3 were evaluated for antioxidant activity by the in vitro DPPH free radical scavenging ability and the protective effect of OH

China’s chronic disease management suffers from problems such as unclear institutional function， insufficient information technology application， and weak regulation support. On the basis of current chronic disease management condition in China， this paper proposes to apply the concept of “people-centered” integrated health management to community chronic disease management and discusses the content and procedure of establishing an integrated community-based chronic disease management model driven by massive databases. The model innovatively combines technology integration， data integration and service integration， and can accurately and efficiently realize the "people-centered" full-course health management of various chronic diseases. Shanghai has provided integrated community-based chronic disease management service for 1.98 million citizens through applying this model. The model warrants further effectiveness and economic evaluation. This study provides precious experience for the development of chronic disease prevention and treatment in China.

Clouston syndrome (OMIM #129500), also known as hidrotic ectodermal dysplasia type 2, is a rare autosomal dominant skin disorder. To date, four mutations in the GJB6 gene, G11R, V37E, A88V, and D50N, have been confirmed to cause this condition. In previous studies, the focus has been mainly on gene sequencing, and there has been a lack of research on clinical manifestations and pathogenesis. To confirm the diagnosis of this pedigree at the molecular level and summarize and analyse the clinical phenotype of patients and to provide a basis for further study of the pathogenesis of the disease, we performed whole-exome and Sanger sequencing on a large Chinese Clouston syndrome pedigree. Detailed clinical examination included histopathology, hair microscopy, and scanning electron microscopy. We found a novel heterozygous missense variant (c.134G>C:p.G45A) for Clouston syndrome. We identified a new clinical phenotype involving all nail needling pain in all patients and found a special honeycomb hole structure in the patients' hair under scanning electron microscopy. Our data reveal that a novel variant (c.134G>C:p.G45A) plays a likely pathogenic role in this pedigree and highlight that genetic testing is necessary for the diagnosis of Clouston syndrome.
Humans ; Connexin 30/genetics* ; Connexins/genetics* ; East Asian People ; Ectodermal Dysplasia/pathology* ; Phenotype